Vertex Pharmaceuticals Incorporated (LON:0QZU)
London
· Delayed Price · Currency is GBP · Price in USD 419.70
-21.11 (-4.79%)
At close: May 14, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 83.55 billion as of May 14, 2025. Its market cap has increased by 1.30% in one year.
Market Cap
83.55B
Enterprise Value
76.24B
Revenue
8.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
419.70
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 83.55B, an increase of 163,052.58%. That is a compound annual growth rate of 24.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.28B |
| GSK plc | 56.88B |
| Haleon | 36.42B |
| Smith & Nephew | 9.45B |
| ConvaTec Group | 5.36B |
| Hikma Pharmaceuticals | 4.31B |
| HUTCHMED (China) | 1.83B |
| Genus | 1.39B |